Patient demand for shockwave therapy is rapidly growing and clinics that don’t offer it risk losing both revenue and loyalty by referring patients elsewhere. A recent Venn Healthcare survey of over 1,000 clinics found that many are already treating an average of 10 patients per week with shockwave, generating around £36,000 a year in additional income. With most patients seeing improvement within 2 - 6 sessions and reporting high satisfaction, the therapy is proving both effective and popular.

Clinically, shockwave is being used across a wide range of musculoskeletal conditions—from plantar fasciitis, Achilles tendinopathy, and tennis elbow, to shoulder injuries, gluteal tendinopathy, shin splints, and even specialist applications like men’s health. Radial devices are the most common entry point, with some clinics combining them with focused systems for complex cases. Effectiveness ratings consistently fall between 4 and 5 out of 5 across these indications.

Financially, shockwave can be transformative. Treating just 20 patients per week can generate over £70,000 annually, with most practices recouping the cost of a radial device in 3 - 6 months thanks to minimal running costs, short treatment times and easy integration. Beyond direct revenue, clinics also benefit from improved patient retention, reduced referrals out and positive word-of-mouth.

Venn Healthcare supports clinics with a full range of devices, flexible finance, training, and ongoing aftercare, making shockwave therapy more accessible than many realise.

https://www.vennhealthcare.com/shockwave-therapy-for-clinics-how-to-meet-patient-demand-and-boost-revenue/